Health Care & Life Sciences » Biotechnology | Akari Therapeutics PLC

Akari Therapeutics PLC ADR | Key People and Executives

Raymond Prudo
Executive Chairman
Clive Stuart Richardson
Chief Executive & Operating Officer, Director
Peter Feldschreiber
Director
Michael Grissinger
Director
Robert E. Ward
Independent Director
James Ferguson Hill
Independent Director
Stuart Ungar
Independent Director
Donald A. Williams
Independent Director
David Byrne
Independent Director
Raymond Prudo
Executive Chairman
Clive Stuart Richardson
Chief Executive & Operating Officer, Director
Dov S. Elefant
Chief Financial Officer
Miles Nunn
Chief Scientific Officer
Wynne Weston-Davies
Medical Director
Nigel A.S. Hernandez
Vice President-Worldwide Regulatory Affairs
Peter Feldschreiber
Director
Michael Grissinger
Director
Robert E. Ward
Independent Director
James Ferguson Hill
Independent Director
Stuart Ungar
Independent Director
Donald A. Williams
Independent Director
David Byrne
Independent Director

About Akari Therapeutics

View Profile
Address
75/76 Wimpole Street
London London & South East W1G 9RT
United Kingdom
Employees -
Website http://akaritx.com
Updated 07/08/2019
Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Coversin, is a second-generation complement inhibitor. The company was founded on October 7, 2004 and is headquartered in London, the United Kingdom.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.